How have EWTX and IDYA total returns compared?

Over the past 5 years, EWTX delivered 16.95% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Edgewise Therapeutics, Inc. (EWTX) vs IDEAYA Biosciences, Inc. (IDYA)

A side-by-side comparison of Edgewise Therapeutics, Inc. and IDEAYA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EWTX

Edgewise Therapeutics, Inc.

$4.36B

$40.55HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT

IDYA

IDEAYA Biosciences, Inc.

$3.54B

$37.27HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT

Total return — EWTX vs IDYA

growth of $100 · dividends reinvested · last 6y

EWTX +34.3% (+5.0%/yr)IDYA +68.4% (+9.1%/yr)IDYA compounded faster over this window

EWTX IDYA

EWTX vs IDYA: by the numbers

•EWTX is the larger company ($4.36B vs $3.54B market cap).
•Both run net losses; EWTX's is the smaller (0.00% vs -74.75% net margin).

Metrics side by side

Valuation

Metric	EWTX	IDYA
P/S ratio	N/A	15.14
P/B ratio	9.74	2.96

Profitability

Metric	EWTX	IDYA
Gross margin	0.00%	-43.89%
Operating margin	0.00%	-72.84%
Net margin	0.00%	-74.75%
ROE	-44.02%	-14.60%
ROIC	-48.57%	-17.68%

Growth (annualized)

Metric	EWTX	IDYA
Revenue CAGR (5Y)	N/A	45.80%
Total return CAGR (5Y)	16.95%	7.32%

Frequently asked

How have EWTX and IDYA total returns compared?: Over the past 5 years, EWTX delivered 16.95% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EWTX analysis Full IDYA analysis Interactive comparison tool

Dig into the metrics

Edgewise Therapeutics ROE IDEAYA Biosciences ROE Edgewise Therapeutics operating margin IDEAYA Biosciences operating margin Edgewise Therapeutics revenue growth IDEAYA Biosciences revenue growth Edgewise Therapeutics free cash flow IDEAYA Biosciences free cash flow

Edgewise Therapeutics & IDEAYA Biosciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.